drugset / Trial / NCT05642429
Study of AV-1959D, an Amyloid Beta Vaccine
Phase 1
Active not recruiting
48 enrolled
Institute for Molecular Medicine
Clinartis · collabNational Institute on Aging (NIA) · collab
RandomizedSequentialTriple-blindTreatment
Summary
Phase 1 clinical trial of AV-1959 amyloid-β vaccine for Alzheimer's disease (AD).
Timeline
- Start
- 2023-02-27
- Primary completion
- 2026-07-20
- Completion
- 2026-11-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AV-1959D | Vaccine | 500 ug | Other |
| Comparator | AV-1959D | Vaccine | 1000 ug | Other |
| Comparator | AV-1959D | Vaccine | 2000 ug | Other |